|
|
|
40
|
1612S
|
DOCETAXEL 80MG INJ (INP/AHI)
|
DOCETAXEL
|
DOCETAXEL
|
80MG VIAL
|
C
|
65.70
|
65.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
1612X
|
DOCETAXEL 80MG INJ (VEN)
|
DOCETAXEL
|
DOCETAXEL
|
4ML VIAL
|
BQ
|
38.4643
|
38.4643
|
VIAL
|
0
|
VIAL
|
VEN
|
VENUS REMEDIES LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
1642G
|
HALOPERIDOL 5MG/ML INJ (STP/COL)
|
HALOPERIDOL
|
HALOPERIDOL
|
100X1ML
|
B
|
165.82
|
1.66
|
INJECTION
|
0
|
AMP
|
STP
|
STEROP LABORATORIES
|
COL
|
COLLINS LTD
|
|
28160808
|
BUTYROPHENES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1642G
|
HALOPERIDOL 5MG/ML INJ (STP) (B)
|
HALOPERIDOL
|
HALOPERIDOL
|
100X1ML
|
B
|
193
|
1.93
|
AMP
|
0
|
BOX
|
STP
|
STEROP LABORATORIES
|
COL
|
COLLINS LTD
|
|
28160808
|
BUTYROPHENES
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BUTYROPHENES
|
|
|
|
|
41
|
1642U
|
HALOPERIDOL 5MG/ML INJ (FSB) (B)
|
HALOPERIDOL
|
HALOPERIDOL
|
10X1ML
|
B
|
5.9
|
0.5899
|
AMP
|
0
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160808
|
BUTYROPHENES
|
2024-04-01
|
2026-03-31
|
|
IM
|
6
|
BUTYROPHENES
|
|
|
|
|
40
|
1642X
|
HALOPERIDOL 5MG/ML INJ (MON/PHA)
|
HALOPERIDOL
|
HALOPERIDOL
|
10X1ML
|
B
|
6.20
|
0.62
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160808
|
BUTYROPHENES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
16441
|
HALOXEM 5MG TAB (REM/SBI) HALOPERIDOL
|
HALOPERIDOL
|
HALOXEM
|
1000'S
|
A
|
73.07
|
0.07
|
TABLET
|
180
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160808
|
BUTYROPHENES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
16441
|
HALOXEN 5MG TAB (REM) HALOPERIDOL
|
HALOPERIDOL
|
HALOXEN
|
1000'S
|
A
|
71.03
|
0.071
|
TAB
|
180
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160808
|
BUTYROPHENES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BUTYROPHENES
|
|
|
|
|
40
|
1644T
|
HALDOL 5MG TAB (JAC/STO) HALOPERIDOL
|
HALOPERIDOL
|
HALDOL
|
20'S
|
C
|
32.27
|
1.61
|
TABLET
|
0
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160808
|
BUTYROPHENES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1644T
|
HALDOL 5MG TAB (JAC) HALOPERIDOL (C)
|
HALOPERIDOL
|
HALDOL
|
20'S
|
C
|
32.27
|
1.6133
|
TAB
|
180
|
BOX
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
28160808
|
BUTYROPHENES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BUTYROPHENES
|
|
|
|
|
41
|
1652C
|
HYDROXYZINE 10MG TAB (WAT)
|
HYDROXYZINE
|
HYDROXYZINE
|
100'S
|
A
|
13.35
|
0.1335
|
TAB
|
90
|
BOX
|
WAT
|
WATSON (ACTAVIS) PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
40
|
1652E
|
AAP-HYDROXYZINE 10MG TAB (APO/COL) HYDROXYZIN
|
HYDROXYZINE
|
AAP-HYDROXYZINE
|
100'S
|
A
|
15.28
|
0.15
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1652G
|
HYDROXYZINE 10MG TAB (CAM)
|
HYDROXYZINE
|
HYDROXYZINE
|
84'S
|
A
|
9.7
|
0.1155
|
TAB
|
90
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
41
|
16539
|
HYDROXYZINE 25MG TAB (WAT)
|
HYDROXYZINE
|
HYDROXYZINE
|
100'S
|
A
|
17.81
|
0.178
|
TAB
|
90
|
BOX
|
WAT
|
WATSON (ACTAVIS) PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
40
|
1653D
|
AAP-HYDROXYZINE 25MG TAB (APO/COL)
|
HYDROXYZINE
|
AAP-HYDROXYZINE
|
100'S
|
A
|
16.99
|
0.17
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1653F
|
AAP-HYDROXYZINE 25MG TAB (APO)
|
HYDROXYZINE
|
AAP-HYDROXYZINE
|
100'S
|
A
|
17.34
|
0.1734
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
|
|
|
40
|
16617
|
APO-OLANZAPINE 2.5MG TAB (APO/COL)
|
OLANZAPINE
|
APO-OLANZAPINE
|
100'S
|
BP
|
28.46
|
0.28
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1661J
|
OLANZAPINE 2.5MG TAB (MCP/AHI)
|
OLANZAPINE
|
OLANZAPINE
|
30'S
|
BP
|
3.32
|
0.11
|
TABLET
|
0
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
1661J
|
OLANZAPINE 2.5MG TAB (MCP) (BP)
|
OLANZAPINE
|
OLANZAPINE
|
30'S
|
BP
|
3.48
|
0.116
|
TAB
|
84
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
41
|
1661M
|
APO-OLANZAPINE 2.5MG TAB (APO) (BP)
|
OLANZAPINE
|
APO-OLANZAPINE
|
100'S
|
BP
|
29.03
|
0.2903
|
TAB
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
